{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:49:05Z","timestamp":1793148545181,"version":"4.5.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0029861","type":"journal-article","created":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T16:46:26Z","timestamp":1326818786000},"page":"e29861","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["High Throughput Screening for Small Molecule Therapy for Gaucher Disease Using Patient Tissue as the Source of Mutant Glucocerebrosidase"],"prefix":"10.1371","volume":"7","author":[{"given":"Ehud","family":"Goldin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Motabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Southall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Marugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.","volume":"103","author":"J Inglese","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.ejmech.2010.01.027","article-title":"Evaluation of 2-thioxo-2,3,5,6,7,8-hexahydropyrimido[4,5-d]pyrimidin-4(1H)-one analogues as GAA activators.","volume":"45","author":"JJ Marugan","year":"2010","journal-title":"Eur J Med Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1875397301004010067","article-title":"High throughput screening for inhibitors of alpha-galactosidase.","volume":"4","author":"O Motabar","year":"2010","journal-title":"Curr Chem Genomics"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1111\/j.1742-4658.2007.06042.x","article-title":"Pharmacologic chaperoning as a strategy to treat Gaucher disease.","volume":"274","author":"Z Yu","year":"2007","journal-title":"FEBS J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"13192","DOI":"10.1073\/pnas.0705637104","article-title":"Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease.","volume":"104","author":"W Zheng","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","first-page":"3635","article-title":"Gaucher Disease.","author":"E Beutler","year":"2001"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2010-03-273151","article-title":"A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.","volume":"116","author":"E Lukina","year":"2010","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1185\/03007990802576518","article-title":"Goal-oriented therapy with miglustat in Gaucher disease.","volume":"25","author":"GM Pastores","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1742-4658.2010.07588.x","article-title":"The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.","volume":"277","author":"R Khanna","year":"2010","journal-title":"FEBS J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease.","volume":"372","author":"GA Grabowski","year":"2008","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","article-title":"Randomized, controlled trial of miglustat in Gaucher's disease type 3.","volume":"64","author":"R Schiffmann","year":"2008","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).","volume":"29","author":"KS Hruska","year":"2008","journal-title":"Hum Mutat"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.","volume":"160","author":"J Charrow","year":"2000","journal-title":"Arch Intern Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pd.1943","article-title":"Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?","volume":"28","author":"F Fares","year":"2008","journal-title":"Prenat Diagn"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.21362","article-title":"The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.","volume":"84","author":"TH Taddei","year":"2009","journal-title":"Am J Hematol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \u201csimple\u201d disorder.","volume":"83","author":"E Sidransky","year":"2004","journal-title":"Mol Genet Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","article-title":"Non-neuronopathic Gaucher disease due to saposin C deficiency.","volume":"72","author":"A Tylki-Szymanska","year":"2007","journal-title":"Clin Genet"},{"key":"ref18","first-page":"442","article-title":"Enabling the large scale analysis of quantitative high throughput screening data.","author":"NT Southall","year":"2009"},{"key":"ref19","article-title":"National Center for Biochenology Information."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0009-8981(81)90251-5","article-title":"An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.","volume":"115","author":"LB Daniels","year":"1981","journal-title":"Clin Chim Acta"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1042\/bj1360821","article-title":"Glucocerebrosidase: reconstitution from macromolecular components depends on acidic phospholipids.","volume":"136","author":"MW Ho","year":"1973","journal-title":"Biochem J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI116276","article-title":"Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.","volume":"91","author":"S van Weely","year":"1993","journal-title":"J Clin Invest"},{"key":"ref23","article-title":"National Center for Biochenology Information."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/jm1008902","article-title":"Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity.","volume":"54","author":"JJ Marugan","year":"2011","journal-title":"J Med Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms.","volume":"103","author":"RA Steet","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbamcr.2008.09.020","article-title":"Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation.","volume":"1793","author":"H Schulze","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1074\/jbc.M110.150433","article-title":"X-ray and biochemical analysis of N370S mutant human acid beta-glucosidase.","volume":"286","author":"RR Wei","year":"2011","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/humu.21121","article-title":"The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase.","volume":"30","author":"JJ Flanagan","year":"2009","journal-title":"Hum Mutat"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0029861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:24:22Z","timestamp":1588969462000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0029861"}},"subtitle":[],"editor":[{"given":"Raphael","family":"Schiffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,17]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0029861","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,17]]}}}